Nerve Growth Factor, a Differentiating Agent, and Epidermal Growth Factor, a Mitogen, Increase the Activities of Different S6 Kinases in PC12 Cells
Overview
Authors
Affiliations
Treatment of PC12 cells with either nerve growth factor, a differentiating agent, or epidermal growth factor, a mitogen, leads to an increase in the phosphorylation of the ribosomal protein S6. The soluble fraction of PC12 cells contains two S6 kinases, separable on heparin-Sepharose. Treatment of the cells with nerve growth factor results in an increase in the activity of one of these kinases; treatment of the cells with epidermal growth factor results in an increase in the activity of the other one. The data suggest that the patterns of phosphorylation and, in turn, the functional properties of S6 are different in cells instructed to differentiate from those in cells instructed to divide.
Shen J, Najafi S, Stable S, Fabian J, Koeneke E, Kolbinger F Cell Death Differ. 2018; 25(12):2053-2070.
PMID: 29515255 PMC: 6261943. DOI: 10.1038/s41418-018-0080-0.
Secondary alterations of sphingolipid metabolism in lysosomal storage diseases.
Prinetti A, Prioni S, Chiricozzi E, Schuchman E, Chigorno V, Sonnino S Neurochem Res. 2011; 36(9):1654-68.
PMID: 21207141 DOI: 10.1007/s11064-010-0380-3.
Deregulated sphingolipid metabolism and membrane organization in neurodegenerative disorders.
Piccinini M, Scandroglio F, Prioni S, Buccinna B, Loberto N, Aureli M Mol Neurobiol. 2010; 41(2-3):314-40.
PMID: 20127207 DOI: 10.1007/s12035-009-8096-6.
Neurotrophic factors for the investigation and treatment of movement disorders.
Garcia de Yebenes J, Sanchez M, Mena M Neurotox Res. 2003; 5(1-2):119-38.
PMID: 12832227 DOI: 10.1007/BF03033377.
Kazazoglou T, Geladopoulos T, Kentroti S, Stefanis C, Vernadakis A Neurochem Res. 1996; 21(5):609-14.
PMID: 8726970 DOI: 10.1007/BF02527760.